Details:

Alternative Title:
Circ Heart Fail
Personal Author:
Tang, Xian-Liang ; Rokosh, Gregg ; Sanganalmath, Santosh K. ; Tokita, Yukichi ; Keith, Matthew C. L. ; ... More +
Tang, Xian-Liang ; Rokosh, Gregg ; Sanganalmath, Santosh K. ; Tokita, Yukichi ; Keith, Matthew C. L. ; Shirk, Gregg ; Stowers, Heather ; Hunt, Gregory N. ; Wu, Wenjian ; Dawn, Buddhadeb ; Bolli, Roberto Less -
Description:
Background

Although c-kitpos cardiac stem cells (CSCs) preserve left ventricular (LV) function and structure after myocardial infarction (MI), CSC doses have been chosen arbitrarily and the dose-effect relationship is unknown.

Methods and Results

Rats underwent a 90-min coronary occlusion followed by 35 days of reperfusion. Vehicle or CSCs at 5 escalating doses (0.3 ×106, 0.75 ×106, 1.5 ×106, 3.0 ×106, and 6.0 ×106 cells/heart) were given intracoronarily 4 h after reperfusion. The lowest dose (0.3 ×106) had no effect on LV function and morphology, whereas 0.75, 1.5, and 3.0 ×106 significantly improved regional and global LV function (echocardiography and hemodynamic studies). These three doses had similar effects on echocardiographic parameters (infarct wall thickening fraction, LV end-systolic and end-diastolic volumes, LV ejection fraction) and hemodynamic variables (LV end-diastolic pressure, LV dP/dtmax, preload adjusted maximal power, end-systolic elastance, preload recruitable stroke work), and produced similar reductions in apoptosis, scar size, infarct wall thinning, and LV expansion index and similar increases in viable myocardium in the risk region (morphometry). Infusion of 6.0 ×106 CSCs markedly increased post-procedural mortality. GFP and BrdU staining indicated that persistence of donor cells and formation of new myocytes were negligible with all doses.

Conclusions

Surprisingly, in this rat model of acute MI, the dose-response relationship for intracoronary CSCs is flat. A minimal dose between 0.3 and 0.75 ×106 is necessary for efficacy; above this threshold, a four-fold increase in cell number does not produce greater improvement in LV function or structure. Further increases in cell dose are harmful.


Subjects:
[+]
Animals Apoptosis Article Biomarkers Capillaries Cardiac Output Cardiac Progenitor Cells Cell Differentiation Cell Proliferation Cells, Cultured Disease Models, Animal Left Ventricular Function Male Myocardial Infarction Myocardial Ischemia Myocardial Regeneration Myocardium Myocytes, Cardiac Neovascularization, Physiologic Proto-Oncogene Proteins C-kit Rats, Inbred F344 Recovery Of Function Regeneration Stem Cells Stem Cell Transplantation Time Factors Tissue Survival Ultrasonography Ventricular Function, Left Ventricular Pressure
Source:
Circ Heart Fail. 8(4):757-765.
Pubmed ID:
25995227
Pubmed Central ID:
PMC4512882
Document Type:
Journal Article
Funding:
R01 HL055757/HL/NHLBI NIH HHS/United States ; R01-HL74351/HL/NHLBI NIH HHS/United States ; 1 UM1 HL-113530/HL/NHLBI NIH HHS/United States ; H75 DP424252/DP/NCCDPHP CDC HHS/United States ; P01 HL078825/HL/NHLBI NIH HHS/United States ; ... More +
R01 HL055757/HL/NHLBI NIH HHS/United States ; R01-HL74351/HL/NHLBI NIH HHS/United States ; 1 UM1 HL-113530/HL/NHLBI NIH HHS/United States ; H75 DP424252/DP/NCCDPHP CDC HHS/United States ; P01 HL078825/HL/NHLBI NIH HHS/United States ; R01 HL074351/HL/NHLBI NIH HHS/United States ; UM1 HL113530/HL/NHLBI NIH HHS/United States ; P01-HL78825/HL/NHLBI NIH HHS/United States ; R01 HL068088/HL/NHLBI NIH HHS/United States Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:fa103c869b2f2fa6f9d7f7f2032ecff2145df641a5456ed6797d3a1db821be68
Download URL:
https://stacks.cdc.gov/view/cdc/32335/cdc_32335_DS1.pdf
File Type:

Supporting Files

• 	nihms693682f3.gif	gif
  	nihms693682f3.jpg	jpeg
  	nihms693682f4.gif	gif
  	nihms693682f4.jpg	jpeg
  	nihms693682f5.gif	gif
  	nihms693682f5.jpg	jpeg
  	nihms693682f6.gif	gif
  	nihms693682f6.jpg	jpeg
  	nihms693682f7.gif	gif
  	nihms693682f7.jpg	jpeg
  	NIHMS693682-supplement-CircHF_CIRCHF-2015-002210_xml.xml
  	nihms693682f8.gif	gif
  	nihms693682f8.jpg	jpeg
  	NIHMS693682-supplement-Clinical_Perspective.docx	docx
  	NIHMS693682-supplement-Supplemental_Material.pdf	pdf
  	nihms693682.nxml	xml
  	nihms693682f1.gif	gif
  	nihms693682f1.jpg	jpeg
  	nihms693682f2.gif	gif
  	nihms693682f2.jpg	jpeg

More +